Beschreibung
Cephalexin may enhance the anticoagulant effect of warfarin, with case reports describing INR elevation during concurrent therapy, likely through disruption of vitamin K-producing gut flora.
Mechanismus
Broad-spectrum antibiotics including cephalexin reduce intestinal bacteria that synthesise menaquinones (vitamin K2), decreasing vitamin K availability and augmenting warfarin's anticoagulant effect.
Klinische Bedeutung
Case reports and observational data link cephalosporin use to supratherapeutic INR values; the interaction is unpredictable in magnitude.
Maßnahmen
Monitor INR within 3–5 days of starting cephalexin in anticoagulated patients; adjust warfarin dose if INR rises above target range.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.